Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

NCT ID
NCT06397677
Registry status
Recruiting
Study type
Observational
Sponsor
University of Colorado, Denver
Conditions
Interstitial Lung Disease, Rheumatoid Arthritis

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)

Enrollment: 450 participants (Estimated).

What is being studied

  • Intervention: Health Care Facilities Workforce and Services
  • Intervention: Health Facilities
  • Diagnostic test: Information Collected as Standard of Care
  • Intervention: Laboratories
  • Intervention: Non-Medical Public and Private Facilities
  • Other: Research Testing Performed
  • Genetic: Research Testing Performed (Laboratory)

Who may be eligible

Ages
18 Years to 90 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria * 18 years of age or older Exclusion Criteria: * Prior medication treatment specifically for RA-ILD * Inability to give informed consent * Pregnant women

Study locations

4 study locations are listed.

Recruiting site status is explicitly provided for 4 locations; 4 are listed as Recruiting.

Countries: United States

  • California, United States: 1
  • Colorado, United States: 1
  • Kansas, United States: 1
  • Michigan, United States: 1

Sample of listed locations

  • University of California San Francisco — San Francisco, California, 94143, United States — Recruiting
  • University of Colorado Denver — Aurora, Colorado, 80045, United States — Recruiting
  • University of Kansas — Kansas City, Kansas, 66103, United States — Recruiting
  • University of Michigan — Ann Arbor, Michigan, 48109, United States — Recruiting

Study details

Start date
January 22, 2024
Primary completion date
January 1, 2029
Completion date
January 1, 2034
First posted
May 3, 2024
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), University of California, San Francisco, University of Kansas, University of Michigan

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT06397677
Registry last updated
May 3, 2024
QualifiedStudies registry data refreshed
October 2, 2026
QualifiedStudies record fetched
October 2, 2026

View NCT06397677 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ